Gender Differences in Receipt of End-of-Life Care

This article originally appeared here.
Share this content:
Gender Differences in Receipt of End-of-Life Care
Gender Differences in Receipt of End-of-Life Care

THURSDAY, May 21, 2015 (HealthDay News) -- There are gender differences in receipt of end-of-life (EoL) care among terminally ill cancer patients, with male patients more likely to receive intensive care unit (ICU) care, according to a study published online May 14 in Cancer.

Rashmi K. Sharma, M.D., from Northwestern University in Chicago, and colleagues conducted a multisite, prospective cohort study involving 353 patients with metastatic cancers who were identified as terminally ill at study enrollment. Participants were interviewed at a median of 4.1 months before their death. The authors examined whether gender differences exist in the receipt of ICU care and the correlation between EoL discussions and receipt of EoL ICU care.

The researchers found that male patients were more likely to receive ICU care at the EoL (73 versus 52 percent; P = 0.02). Male patients reporting an EoL discussion were less likely than those not reporting a discussion to have an ICU stay in the last week of life, after adjustment for potential confounders (adjusted odds ratio, 0.26; P = 0.04). Among female patients there was no correlation between EoL discussions and ICU stays near death.

"Gender differences in the effects of EoL discussions on EoL care likely contribute to and may even explain gender differences in the receipt of ICU care in the last week of life," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »